Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
985397
Reference Type
Journal Article
Title
Clinical pharmacology of the combination of ACE inhibitors and calcium antagonists: benefits of the perindopril arginine and amlodipine combination
Author(s)
Leonova, MV
Year
2010
Is Peer Reviewed?
1
Journal
Kardiovaskulyarnaya Terapiya i Profilaktika
ISSN:
1728-8800
Volume
9
Issue
8
Page Numbers
55-62
Web of Science Id
WOS:000286486200009
Abstract
The paper reviews the modern evidence on mechanisms of action and clinical effectiveness of two cardiovascular medication classes angiotensin-converting enzyme (ACE) inhibitors and calcium antagonists (CA), used for the treatment of patients with arterial hypertension (AH) and coronary heart disease (CH D). ACE inhibitors and CA have complementary effects on vascular tone and endothelial function, as well as synergetic action in terms of blood pressure (BP) reduction, pleiotropic effects, organo-protection, and clinical event prevention. Therefore, these mediations can be used as combined cardiovascular therapy. Perindopril and amlodipine, both as monotherapy or combined treatment, have the largest evidence base and potential for clinical practice.
Keywords
Renin-angiotensin system; endothelial dysfunction; ACE inhibitors; calcium antagonists; arterial hypertension; coronary heart disease
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity